Remove 2026 Remove Pharma Companies Remove Pharmaceuticals
article thumbnail

Changes to UK Statutory Scheme go ahead despite pharma criticism

Drug Discovery World

It intends to set amended payment percentages for 2024 to 2026 based on an allowed growth rate that has been increased to 2%. This means that companies will pay a rebate on the sales of branded medicines to the NHS of 21.9% before this year, according to the Association of the British Pharmaceutical Industry (ABPI).

article thumbnail

The building blocks of AI success stories

Drug Discovery World

From pharma to non-profit “I probably wouldn’t have the role I have now if I hadn’t worked for SLAS,” Tarselli reflects. What followed was his move from a large pharmaceutical conglomerate to a non-profit organisation. If I hadn’t had that,” he says, “I would certainly not be working at Tetra, today.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

As one of the exciting fields in the pharmaceutical industry, it’s no surprise that Drug Discovery 2022 will feature sessions on developments in CAR-T and the technologies helping researchers in this field. . This year has seen some major deals announced by big pharma companies. Recently, the project was awarded £3.5

Drugs 130
article thumbnail

Fibrosis research: Advances and challenges 

Drug Discovery World

Once the big pharma companies join the race for a specific disease or target, the window of opportunity to be successful as an independent biotech company is already closed. He has over 30 years of R&D experience in the pharmaceutical and biotechnology industry. You need to set the bar higher.